A Randomized, Placebo-Controlled Phase 3 Trial of the PI3K8 Inhibitor Leniolisib for Activated PI3K8 Syndrome
BLOOD（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined